Although some specific markers have been used to identify or purify CSCs, e.g. CD133 or CXCR4 in PrC [9–11], it is gradually realized that a single marker or combined a few markers is not sufficient to allow definition and purification of CSCs in tumor [16]. The gene discussed is PROM1; the disease is neoplasm.